Skip to Main content Skip to Navigation
Journal articles

Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial

Abstract : Objectives:-To describe the evolution of the SARS-CoV-2 salivary viral load of patients infected with Covid-19, performing 7 days of tri-daily mouthwashes with and without antivirals.-To compare the evolution of the SARS-CoV-2 nasal and salivary viral load according to the presence or absence of antivirals in the mouthwash. Trial design: This is a multi-center, randomised controlled trial (RCT) with two parallel arms (1:1 ratio). Participants: Inclusion criteria-Age: 18-85 years old-Clinical diagnosis of Covid-19 infection-Clinical signs have been present for less than 8 days-Virological confirmation-Understanding and acceptance of the trial-Written agreement to participate in the trial Exclusion criteria-Pregnancy, breastfeeding, inability to comply with protocol, lack of written agreement-Patients using mouthwash on a regular basis (more than once a week)-Patient at risk of infectious endocarditis-Patients unable to answer questions-Uncooperative patient The clinical trial is being conducted with the collaboration of three French hospital centers: Hospital Center Emile Roux (Le Puy en Velay, France), Clinic of the Protestant Infirmary (Lyon, France) and Intercommunal Hospital Center (Mont de Marsan, France).
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02991374
Contributor : Florence Carrouel <>
Submitted on : Friday, November 6, 2020 - 1:09:13 AM
Last modification on : Friday, November 13, 2020 - 3:22:55 AM

File

Carrouel et al Trial 2020.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Florence Carrouel, Stéphane Viennot, Martine Valette, Jean-Marie Cohen, Claude Dussart, et al.. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial. Trials, BioMed Central, 2020, 21, ⟨10.1186/s13063-020-04846-6⟩. ⟨hal-02991374⟩

Share

Metrics

Record views

25

Files downloads

9